Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PHOENIX BIOTECH ACQUISITION CORP.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss... |
| 07/03/2023 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits Interactive Data |
| 01/27/2023 |
8-K
| Other Events Interactive Data |
| 12/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/07/2022 |
8-K
| Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits ...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Termination Agreement",
"Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement Seattle, WA, December 6, 2022 — Intrinsic Medicine, Inc. , a therapeutics company leveraging human milk biology to transform Gut-Brain Axis and inflammatory disorders, and Phoenix Biotech Acquisition Corp. , a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with one or more businesses, today announced the mutual termination of their previously announced business combination agreement due to current market conditions. “Intrinsic was encouraged by the positive feedback from prospective investors regarding the attractiveness of our novel and capital-efficient approach to developing transformative ne..." |
|
| 10/15/2021 |
8-K
| Quarterly results |
| 10/12/2021 |
8-K
| Quarterly results |
|
|